Cargando…
Potential Protection Against Type 2 Diabetes in Obesity Through Lower CD36 Expression and Improved Exocytosis in β-Cells
Obesity is a risk factor for type 2 diabetes (T2D); however, not all obese individuals develop the disease. In this study, we aimed to investigate the cause of differential insulin secretion capacity of pancreatic islets from donors with T2D and non-T2D (ND), especially obese donors (BMI ≥30 kg/m(2)...
Autores principales: | Nagao, Mototsugu, Esguerra, Jonathan L.S., Asai, Akira, Ofori, Jones K., Edlund, Anna, Wendt, Anna, Sugihara, Hitoshi, Wollheim, Claes B., Oikawa, Shinichi, Eliasson, Lena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243297/ https://www.ncbi.nlm.nih.gov/pubmed/32198214 http://dx.doi.org/10.2337/db19-0944 |
Ejemplares similares
-
CFTR and Anoctamin 1 (ANO1) contribute to cAMP amplified exocytosis and insulin secretion in human and murine pancreatic beta-cells
por: Edlund, Anna, et al.
Publicado: (2014) -
Reduced Insulin Exocytosis in Human Pancreatic β-Cells With Gene Variants Linked to Type 2 Diabetes
por: Rosengren, Anders H., et al.
Publicado: (2012) -
Glucocorticoid induces human beta cell dysfunction by involving riborepressor GAS5 LincRNA
por: Esguerra, Jonathan L.S., et al.
Publicado: (2019) -
Repetitive Glucose Spikes Accelerate Atherosclerotic Lesion Formation in C57BL/6 Mice
por: Shuto, Yuki, et al.
Publicado: (2015) -
Elevated miR-130a/miR130b/miR-152 expression reduces intracellular ATP levels in the pancreatic beta cell
por: Ofori, Jones K., et al.
Publicado: (2017)